A Pilot Study of the Safety and Efficacy of SEP-226330 in Subjects with Restless Legs Syndrome

Registry ID

EUCTR2004-003661-33

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Sepracor, Inc.

Start date

2005-01-19

Last update

2026-08-16

Conditions

• Restless Legs Syndrome (RLS)

Summary

The primary objective is to compare the efficacy of SEP-226330 in subjects with Restless Legs Syndrome (RLS) to placebo, as measured by the change from baseline to the end of treatment in the International Restless Legs Syndrome Study Group (IRLSSG) score.

Locations

• , , Iceland

Related clinical trials

• Optimizing Extended-Duration (XD-) TOMAC Therapy for Restless Legs Syndrome (RLS)

View on source registry